Sovipostobart, CAS 2649371-19-5

Product Description: Sovipostobart is an immunoglobulin G1-kappa, anti-CTLA-4 human monoclonal antibody with cleavable prodomain. Sovipostobart is an immunostimulant and antineoplastic[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 4, 2022.

CAS Number: 2649371-19-5

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CTLA-4

• Artikelnummer: MEXHY-P990080-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P990080-0
• Green Labware: Nein
• Verpackungseinheit: Get quote
• Mengeneinheit: STK